118 related articles for article (PubMed ID: 30504386)
21. Synergistic and additive effects of modified citrus pectin with two polybotanical compounds, in the suppression of invasive behavior of human breast and prostate cancer cells.
Jiang J; Eliaz I; Sliva D
Integr Cancer Ther; 2013 Mar; 12(2):145-52. PubMed ID: 22532035
[TBL] [Abstract][Full Text] [Related]
22. Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells.
Ko HS; Kim JS; Cho SM; Lee HJ; Ahn KS; Kim SH; Lee EO
Bioorg Med Chem Lett; 2014 Feb; 24(4):1176-9. PubMed ID: 24440300
[TBL] [Abstract][Full Text] [Related]
23. NFkappaB-dependent regulation of urokinase plasminogen activator by proanthocyanidin-rich grape seed extract: effect on invasion by prostate cancer cells.
Uchino R; Madhyastha R; Madhyastha H; Dhungana S; Nakajima Y; Omura S; Maruyama M
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):528-33. PubMed ID: 20502321
[TBL] [Abstract][Full Text] [Related]
24. TMPRSS4 upregulates uPA gene expression through JNK signaling activation to induce cancer cell invasion.
Min HJ; Lee Y; Zhao XF; Park YK; Lee MK; Lee JW; Kim S
Cell Signal; 2014 Feb; 26(2):398-408. PubMed ID: 23978400
[TBL] [Abstract][Full Text] [Related]
25. Iron stimulates urokinase plasminogen activator expression and activates NF-kappa B in human prostate cancer cells.
Ornstein DL; Zacharski LR
Nutr Cancer; 2007; 58(1):115-26. PubMed ID: 17571974
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
Murali AK; Norris JS
J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
[TBL] [Abstract][Full Text] [Related]
28. Androgen receptor inhibits epithelial-mesenchymal transition, migration, and invasion of PC-3 prostate cancer cells.
Huo C; Kao YH; Chuu CP
Cancer Lett; 2015 Dec; 369(1):103-11. PubMed ID: 26297988
[TBL] [Abstract][Full Text] [Related]
29. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
30. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
[TBL] [Abstract][Full Text] [Related]
31. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
[TBL] [Abstract][Full Text] [Related]
32. Identification of genes regulating migration and invasion using a new model of metastatic prostate cancer.
Banyard J; Chung I; Migliozzi M; Phan DT; Wilson AM; Zetter BR; Bielenberg DR
BMC Cancer; 2014 May; 14():387. PubMed ID: 24885350
[TBL] [Abstract][Full Text] [Related]
33. Downregulated expression of hepatoma-derived growth factor inhibits migration and invasion of prostate cancer cells by suppressing epithelial-mesenchymal transition and MMP2, MMP9.
Yang F; Yu N; Wang H; Zhang C; Zhang Z; Li Y; Li D; Yan L; Liu H; Xu Z
PLoS One; 2018; 13(1):e0190725. PubMed ID: 29300772
[TBL] [Abstract][Full Text] [Related]
34. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
Huang SY; Chang SF; Liao KF; Chiu SC
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757590
[TBL] [Abstract][Full Text] [Related]
35. Pamidronate down-regulates urokinase-type plasminogen activator expression in PC-3 prostate cancer cells.
Iguchi K; Tatsuda Y; Usui S; Hirano K
Anticancer Res; 2007; 27(6B):3843-8. PubMed ID: 18225541
[TBL] [Abstract][Full Text] [Related]
36. Apigenin inhibits migration and invasion via modulation of epithelial mesenchymal transition in prostate cancer.
Zhu Y; Wu J; Li S; Wang X; Liang Z; Xu X; Xu X; Hu Z; Lin Y; Chen H; Qin J; Mao Q; Xie L
Mol Med Rep; 2015 Feb; 11(2):1004-8. PubMed ID: 25351792
[TBL] [Abstract][Full Text] [Related]
37. Deregulated expression of urokinase and its inhibitor type 1 in prostate cancer cells: role of epigenetic mechanisms.
Hagelgans A; Menschikowski M; Fuessel S; Nacke B; Arneth BM; Wirth MP; Siegert G
Exp Mol Pathol; 2013 Jun; 94(3):458-65. PubMed ID: 23541763
[TBL] [Abstract][Full Text] [Related]
38. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition.
Khan MA; Tania M; Wei C; Mei Z; Fu S; Cheng J; Xu J; Fu J
Oncotarget; 2015 Aug; 6(23):19580-91. PubMed ID: 26023736
[TBL] [Abstract][Full Text] [Related]
39. In vitro anti-invasive effects of N-(4-hydroxyphenyl)-retinamide on human prostatic adenocarcinoma.
Kim JH; Tanabe T; Chodak GW; Rukstalis DB
Anticancer Res; 1995; 15(4):1429-34. PubMed ID: 7654032
[TBL] [Abstract][Full Text] [Related]
40. MiR-181a promotes epithelial to mesenchymal transition of prostate cancer cells by targeting TGIF2.
Zhiping C; Shijun T; Linhui W; Yapei W; Lianxi Q; Qiang D
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4835-4843. PubMed ID: 29164579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]